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Risk management
A personal perspective
Leone Ridsdale offers a personal perspective on the introduction of electronic medical records and 
their use in preventive care. She outlines the possibility of using this approach to identify risks for 
avoidable deaths in epilepsy – and reduce them
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Many years ago, I qualified as a neurologist in Montreal. When I moved to the UK, I 
initially found my specialist 
qualifications were not recognised. I 
trained as a GP and did a weekly 
neurology clinic at my local district 
hospital. There, I saw patients newly 
referred from my colleagues in general 
practice and some follow-ups.
Most patients waited about six 
months for a new referral, and 
another six months for investigations 
and a follow-up appointment. The 
hospital provided only two half-day 
neurology clinics, so many patients 
referred for loss of consciousness/
epilepsy and headache/migraine were 
seen by general physicians. 
Investigations included a technetium 
scan and an EEG. I had trained in a 
university hospital with a computer 
scanner. Neither of the above tests 
gave me much confidence that we 
could exclude important pathology 
like a brain tumour.
Things have improved a lot since 
then. The numbers of neurologists 
have increased more than three-fold. 
Most district hospitals have 
sophisticated magnetic resonance 
imaging (MRI). However, it seems to 
me that more could still be done to 
help people with long-term conditions 
in the community.
When I entered primary care it 
was just beginning to change, shifting 
from a demand-led, reactive service to 
one that was working in teams to 
provide preventive services and 
manage long-term conditions. Ideas 
were promulgated by the Royal 
College of General Practitioners and 
by visionary clinician-researchers, such 
as Julian Tudor Hart. This inspired GP 
made famous an idea he called the 
Inverse Care Law (Tudor Hart, 1971).
Tudor Hart proposed that the 
people with greater needs for 
healthcare may be less likely to access 
it. In poor countries or market-driven 
health services, this may be because 
those in need cannot pay for services. 
In the NHS, it may be because 
individuals do not know they would 
benefit from particular services, so 
they do not come forward to ask for 
them.
An early example I found in 
general practice was cervical cancer, 
which – in England and Wales in 1980 
– caused over 2,000 deaths each year. 
If women came and asked their GP for 
a cervical screening test (then known 
as a ‘smear’ test), it would be provided. 
These women would then be recalled 
at given intervals for repeat tests. 
However, many women – particularly 
those with a lower level of education 
– did not know that they could (and 
should) be screened. As a result, these 
people were more likely to die from 
the disease.
In an attempt to combat this, GPs 
(including myself) began to offer 
screening to women, initially aged 
36-60 (Ridsdale, 1987). The 
Department of Health, with Edwina 
Currie as a Health Minister, 
subsequently launched a national 
programme of cervical screening, and 
now, deaths from cervical cancer have 
decreased by over half (NHS, 2013).
Being proactive
Risk management is now a common 
idea and practice. Even banks do it. 
GPs have grown increasingly expert at 
managing risk.
The introduction of computers 
and computer software has been 
important in enabling GPs to record 
detailed information about all their 
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registered patients. In turn, this 
information allowed them to target 
the offer of specific services to 
appropriate groups – including those 
who do not come forward so readily. 
Targeting of services might be on the 
basis of gender in the case of cervical 
screening, age in the case of 
immunisation, or disease risk factors 
– for example, those with obesity and 
raised cholesterol – who are at risk of 
cardiovascular disease.
The additional work required to 
catalogue information about registered 
patients and deliver targeted 
preventive initiatives required the 
recruitment of increasing numbers of 
team members. These included 
managers, nurses and IT staff. Funding 
and remuneration for meeting targets 
was linked to practices producing data 
about the numbers and percentages of 
registered patients who had received 
primary and secondary preventive 
services. This was associated with 
better NHS outcomes, like decreasing 
deaths from heart disease and cancer 
(Dzeshka et al, 2015, Hamilton et al, 
2013).
After our practice nurses led on 
cervical cancer screening, the local 
commissioners offered a group, 
including myself, some additional 
funding to audit epilepsy services. We 
decided it would be constructive to 
see if a nurse might invite everyone 
registered with epilepsy for advice on 
epilepsy self-management. The nurse 
had worked in the community as a 
health visitor and district nurse, and 
had some added training in epilepsy.
We found that the response was 
good. The sessions allowed practices 
to create a structured record of the 
information that patients had been 
provided on topics like driving, alcohol 
intake and preventing accidents 
(Ridsdale et al, 1997). During the 
1990s, many nurse-led, condition-
specific clinics were set up, financially 
supported by the NHS. This helped to 
pay for the staff required. However, 
epilepsy advice and monitoring was 
not reimbursed.
Information translated into 
knowledge seems important to the 
effective self-management of long-
term conditions. We therefore asked 
people with epilepsy who were 
registered with our local practices to 
complete epilepsy knowledge 
questionnaires. As a result, we learned 
more about their knowledge of 
epilepsy. Our patients had experienced 
their condition for over 20 years (on 
average), but their knowledge of 
epilepsy varied a lot.
Those who had been at school 
longer, who had more qualifications 
and who belonged to self-help groups 
had more epilepsy-specific knowledge 
(Ridsdale et al, 1999a). It seemed as 
though the inverse care law also 
applied in epilepsy. It was another 
example of Tudor Hart’s Inverse Care 
Law. If knowledge of a condition is 
important in self-management, it is 
likely that those who have less of it 
will experience more negative impact 
on the quality of their lives (Ridsdale, 
2009).
It is difficult to show a change in 
knowledge when people have 
experienced a condition for many 
years. That said, knowing that people 
with epilepsy were satisfied with 
additional information provided by a 
nurse was encouraging (Ridsdale et al, 
1999b).
We wondered if specialist nurses 
providing education on self-care might 
be most helpful after epilepsy was first 
diagnosed. We found that it was 
particularly the quarter of people who 
beforehand knew least about epilepsy 
that most improved their knowledge 
of the condition after step-up care 
with a specialist nurse (Ridsdale et al, 
2000).
It seems likely to me that the 
growing number of nurses with an 
interest in epilepsy will improve 
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opportunities, particularly for people 
who know less about the condition to 
learn self-management skills within the 
context of their lives. This role is 
rather similar to the educational role 
played by a health visitor for young 
mothers, responsible for a family. 
Epilepsy in QOF
I was delighted when the late Helen 
Lester asked me to contribute as chair 
to reviewing evidence for the inclusion 
of epilepsy-specific indicators in the 
Quality and Outcomes Framework 
(QOF). The addition of only a few 
points for epilepsy seemed 
appropriate at first, primarily to fund a 
register of patients with epilepsy and 
their monitoring.
I believe that a similar framework 
for services might be provided as it is 
for people with diabetes, in which a 
set tariff rewards the delivery of a 
bundle of services. As part of QOF, 
newly diagnosed patients with 
diabetes are referred for a structured 
education programme. In diabetes, 
nurse specialists also visit practices, 
and directly advise GPs and patients 
with more complex problems. I hope 
that we can learn from this, and ask 
that these sorts of structured services 
are funded for epilepsy. Increased 
capacity and better training will enable 
us to provide step-up services in the 
community.
By comparison to randomised 
trials, testing the effectiveness of drugs, 
testing what are sometimes called 
complex interventions – by which we 
usually mean specific, standardised 
innovations in services – is difficult. In 
addition, such randomised trials of say 
a nurse specialist service are not so 
amply funded as pharmaceutical 
research. Nevertheless, I learned from 
our earlier research in the community 
that the cost of not offering proactive 
care for people with epilepsy was high.
Not only is attending an 
emergency department for an 
epileptic seizure upsetting for the 
individual, their families and friends, it 
is also costly for the NHS. With 
colleagues, I was later able to describe 
why people with epilepsy come to 
emergency departments and exactly 
what the cost is (Noble et al, 2014, 
Ridsdale et al, 2012). When people 
with epilepsy experience seizures that 
are witnessed by family members or 
others, it is understandable that they 
worry about the risk of death. This is 
arguably made worse by the fact that 
their actual risks are often not 
explained to them. Where it has been 
explored, the evidence is that people 
with epilepsy do want to know their 
risks of sudden death (Tonberg et al, 
2015). People with epilepsy who are 
more highly educated are more likely 
to know about this risk (Kroner et al, 
2014), another example of inequalities 
affecting peoples’ knowledge of health 
and health risk (Tudor Hart, 1971).
 I was encouraged by the success 
of risk identification programmes for 
cancer and cardiovascular disease. I 
was similarly encouraged by emerging 
evidence that people want to know 
about their epilepsy risks too, despite 
unequal access to this information. The 
addition of epilepsy to QOF and the 
availability of GP electronic records 
(which provide a database 
representative of the UK population) 
stimulated my colleagues and I to 
undertake an analysis. We analysed 
anonymised GP records of people 
with epilepsy between 1993 and 2007 
(Ridsdale et al, 2011). Research 
subjects included anyone diagnosed 
with epilepsy and then prescribed 
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anti-epileptic medication. ‘Cases’ were 
defined as people with epilepsy who 
died from all causes. Cases were 
compared to ‘controls’, who were 
defined as people with epilepsy still 
alive at the end of the study period.
We found that deaths from all 
causes in people with epilepsy actually 
rose between 1993 and 2005 – at a 
time when mortality from all causes in 
the general population were in decline. 
We compared the group of patients 
with epilepsy who had died to patients 
who had not died during the study 
period. Patients who had alcohol 
problems were at almost three-fold 
increased risk of premature death. 
Risk in patients who had not collected 
their most recent anticonvulsant 
prescription for between 90 and 182 
days was nearly doubled. Having ‘a 
history of injury’ during the previous 
year increased the risk by 40 per cent. 
Having been treated for depression 
increased the risk by about the same 
amount. Patients who had been 
seizure-free in the previous 12 months 
had a 22 per cent reduced risk of 
dying.
In a recent BMJ editorial, I outlined 
what might be done in general 
practice in the future (Ridsdale, 2015). 
This was endorsed in a letter to the 
editor from Philip Smith, on behalf of 
the Association of British Neurology. 
The model includes developing 
risk-assessment tools for epilepsy, just 
as has been done for cardio-vascular 
disease and cancer (Dzeshka et al, 
2015, Hamilton et al, 2013). If GPs 
have a funded programme to perform 
risk assessment, there is much that 
might be offered to improve services 
and potentially reduce deaths. For 
example, medication adherence is 
something that can be monitored and 
discussed with patients at review. 
Smithson et al (2013) demonstrated 
that GPs can identify people who have 
not adhered to epilepsy medication 
and discuss this with them. A court in 
Scotland has argued that pharmacists 
and GPs should be involved in 
monitoring the uptake of 
anticonvulsant medications, and in 
explaining why this is important 
(Judiciary of Scotland, 2011). This 
could be rewarded by QOF. 
Incremental change
Sometimes I ask myself: why is so little 
social or press space given to epilepsy? 
We are currently testing self-
management workshops for people 
with epilepsy who attend hospital 
clinics with persistent seizures 
(Kralj-Hans et al, 2014). I have 
attended and taught some of them. We 
teach that up to one per cent of the 
population have epilepsy. At first I was 
surprised that most participants say 
that before coming they had either 
met no one or only one person with 
epilepsy. Then they add, laughing, that 
they have now met 10! Many people 
with epilepsy are barely aware of each 
other; it seems unsurprising that 
public and policymakers are barely 
aware of them. Why is this?
Scambler and Hopkins described 
how people with epilepsy report 
experiencing what they described as 
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‘felt’ and ‘enacted’ stigma (Scambler 
and Hopkins, 1986). [Felt stigma is an 
internalised sense of shame and the 
expectation of enacted stigma, while 
enacted stigma is a more concrete 
experience of unfair treatment.] To a 
certain extent this still holds. We 
notice stigma is particularly challenging 
for people from some ethic cultures 
(Sonecha et al, 2014). The perception 
of stigma reduces people’s willingness 
to talk, making them less socially 
visible and less supported in learning 
to manage and cope. It also means 
that society is less aware of them, and 
policymakers spend less on epilepsy 
research than its prevalence and 
impact warrants (Gross et al, 1999). 
Arguably, if ‘felt’ stigma results in social 
invisibility, one consequence is that 
society ‘enacts’ stigma by allocating 
less resources for services for people 
with epilepsy. 
The government estimates it 
spends £175 million per annum on the 
identification of those at risk from 
cervical cancer in primary care, 
referral for monitoring to secondary 
care, and surgical intervention (NHS, 
2013). Year-on-year expenditure to 
provide the necessary capacity and 
framework has resulted in the 
development of an excellent 
programme, which has more than 
halved the number of deaths from 
cervical cancer.
In 2013, total deaths in epilepsy 
– excluding status epilepticus – were 
967 in England and Wales (Office of 
National Statistics, 2014). They 
outnumber deaths from cervical 
cancer. In the same year, sudden 
unexpected deaths in epilepsy were 
estimated to be 2,750 in the United 
States, with just under 4,000 deaths in 
Europe (Thurman et al, 2014). These 
people are often young, meaning that 
more years of life are lost in these 
cases than with any other neurological 
condition, except stroke (Thurman et 
al, 2014). It will be helpful to model 
the estimated cost of these years of 
life lost.
Organisations like Epilepsy Action 
and SUDEP Action are to be 
congratulated on their passion to 
create space for epilepsy in the mind 
of society. That space should be 
proportionate to the frequency of 
epilepsy and its impact on lives. Its 
creation is prerequisite to government 
funding that will support better 
research and services. Change always 
seems slow to those who feel 
passionately – but slow change is 
change nonetheless. I believe that 
there is much still to be done that can 
improve self-management for people 
with epilepsy – and general practice is 
a good place to start.
Papers cited by the author are 
directly available at researchgate.net/
profile/Leone_Ridsdale/publications
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